A new analogous model for the detection and evaluation of chemotherapeutic products effective in leprosy.
D000814:Aniline Compounds / Q000097:blood / Q000627:therapeutic use; D000818:Animals; D003622:Dapsone / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004338:Drug Combinations; D005000:Ethionamide / Q000097:blood / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000097:blood / Q000627:therapeutic use*; D007918:Leprosy / Q000188:drug therapy*; D051379:Mice; D008954:Models, Biological; D009164:Mycobacterium Infections / Q000188:drug therapy*; D010619:Phenazines / Q000627:therapeutic use; D011719:Pyrazines / Q000097:blood / Q000627:therapeutic use*; D011817:Rabbits; D012293:Rifampin / Q000097:blood / Q000627:therapeutic use*; D013449:Sulfonamides / Q000097:blood / Q000627:therapeutic use; D014295:Trimethoprim / Q000097:blood / Q000627:therapeutic use
D000814:Aniline Compounds; D004338:Drug Combinations; D010619:Phenazines; D011719:Pyrazines; D013449:Sulfonamides; D003622:Dapsone; D014295:Trimethoprim; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin